Positive results for Amgen's Repatha for high cholesterol patients who cant...
US biotech firm Amgen has released encouraging Phase III data on statinintolerant patients with high
View ArticleACC 2016 Highlights
The American College of Cardiology ACC recently completed their annual meeting which was held in Chicago from Saturday April 2 to Monday April 4.Here areÂthe top news that came out of the conference...
View ArticleVIDEO Statins targeting BP may help reduce CV risks in type 2 diabetes
BOSTON In this video exclusive Naveed Sattar PhD FRCP FRCPath professor of metabolic medicine at the University of Glasgow discusses his presentation on the effect of statins and lowering blood...
View ArticleHow a metabolic pathway promotes breast cancer metastasis
Rockefeller University Press A metabolic pathway that is upregulated in some breast cancers promotes the disease's progression by activating a signaling protein called Arf6 according to a paper...
View ArticleVIDEO PCSK9 inhibitor attractive treatment option for statin intolerance
CHICAGO In this video exclusive Kim A. Eagle MD director of the Frankel Cardiovascular Center at the University of Michigan discusses results of the GAUSS3 trial which showed that statinintolerant...
View ArticleACC Placebo Challenge for Statin Intolerance
MedPage Today Cardiologists debate whether strategy might work in the clinic too
View ArticleFruit may be good for you but dont ditch the statins
"Daily fresh fruit lowers heart death risk as much as statins" The Daily Telegraph reports. A study of over a half a million Chinese people found that a diet rich in fresh fruit was...
View ArticleFriday Feedback Does Latest Trial Provide New HOPE for Statin Therapy
MedPage Today Results were positive but are they practicechanging
View ArticleApr 8 Cardiology News
From ACC rate vs rhythm for postop AF TAVR in intermediaterisk AS PCSK9 inhibitors for statin intolerance HOPE3 and FIRE and ICE are discussed as well as the approval of a leadless pacemaker....
View ArticleACC.16 Evolocumab lowers LDL cholesterol significantly more than ezetimibe in...
After 24 weeks patients with a history of musclerelated statin intolerance and high levels of lowdensity lipoprotein LDL cholesterol who received evolocumab had significant reductions in LDL...
View ArticleStatin use varies among Hispanic adults at risk for CVD
In Hispanic American adults at high risk for CVD lack of health insurance was associated with lower statin use according to new data published in the Journal of the American Heart...
View ArticleREPRIEVE Largest HIVrelated Cardiovascular Disease Clinical Trial Ever...
Landmark Study Investigating Preventative Approach to HIVrelated Heart Disease Marks Significant Progress After One YearBoston MA PRWEB April 12 2016 One year ago the National Institutes of Healths...
View ArticleStatin therapy considered for thyroid eye disease
VANCOUVER British Columbia Statins show promise as a lowrisk diseasemodifying agent for treating thyroid eye disease for which smoking is seen as the only modifiable risk factor. A hyperosmotic shift...
View ArticleLiver Cancer Rate Predicted to Decline by 2030 Cancer Network and OncoTherapy...
MedPage Today Statin use may cut liver cancer risk
View ArticleStatin use linked to reduced mortality after esophageal cancer diagnosis
Use of statins after a diagnosis of esophageal adenocarcinoma was found to be associated with reduced esophageal cancerspecific and allcause mortality according to the results of a large...
View ArticleStudy seeks to clarify true incidence of statin intolerance
Around 40 of patients experienced intolerable muscle symptoms during atorvastatin treatment but not with placebo.
View ArticleStatin Use May Protect Against NASH Fibrosis in NAFLD
Nonalcoholic fatty liver disease NAFLD patients who take statins are less likely to have nonalcoholic steatohepatitis NASH and significant fibrosis new findings have shown. Reuters Health Information
View ArticleAuthors&x2019; reply to Perry
We thank Perry for raising the interesting difference between research trials where both patients and staff are blinded to whether the tablet is really a statin and everyday practice where patients...
View ArticleVIDEO Statin intolerance a real phenomenon
CHICAGO In this video exclusive Steven E. Nissen MD presents results of the GAUSS3 trial which investigated LDL reduction with evolocumab compared with ezetimibe in patients with statin intolerance.The...
View ArticlePCSK9 Inhibitors for Statin Intolerance Early Beta Blockade in AMI
Drs Harrington and Ohman debate PCSK9 inhibitors for statin intolerance and the use of early beta blockade in acute MI in the context of the GAUSS3 and EarlyBAMI latebreaking studies from ACC....
View Article